https://www.nasdaq.com/press-release/bausch-health-to-participate-at-the-40th-annual-j.p.-morgan-healthcare-conference
https://www.nasdaq.com/press-release/new-survey-from-bausch-lomb-and-glaucoma-research-foundation-reveals-emotional-and
https://www.nasdaq.com/press-release/relistorr-methylnaltrexone-bromide-data-is-published-in-the-journal-of-emergency
https://www.nasdaq.com/press-release/apma-grants-seal-of-approval-for-jubliar-efinaconazole-topical-solution-10-2021-12-06
https://www.nasdaq.com/press-release/salix-brings-educational-resources-on-constipation-into-the-homes-of-patients-and
https://www.nasdaq.com/press-release/bausch-lomb-reports-more-than-41-million-units-of-contact-lens-eye-and-lens-care
https://www.nasdaq.com/press-release/salix-will-share-new-rifaximin-data-at-aaslds-the-liver-meetingtm-2021-2021-11-11
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2021-11-04
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-third-quarter-2021-results-2021-11-02
https://www.nasdaq.com/press-release/bausch-lomb-will-present-scientific-data-and-analyses-during-the-american-academy-of
https://www.nasdaq.com/press-release/bausch-lomb-launches-biotruer-eye-care-recycling-program-in-collaboration-with
https://www.nasdaq.com/press-release/new-report-reveals-barriers-to-quality-care-for-chronic-liver-disease-patients-a
https://www.nasdaq.com/press-release/salix-will-feature-new-data-at-the-american-college-of-gastroenterologyr-2021-annual
https://www.nasdaq.com/press-release/bausch-lomb-and-clearside-biomedical-announce-fda-approval-of-xiperetm-triamcinolone
https://www.nasdaq.com/press-release/bausch-health-announces-tom-vadaketh-will-join-bausch-pharma-as-chief-financial
https://www.nasdaq.com/press-release/ortho-dermatologics-to-present-new-data-at-the-2021-fall-clinical-dermatology
https://www.nasdaq.com/press-release/bausch-lomb%3a-positive-outcomes-for-premium-luxsmarttm-intraocular-lenses-following
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-third-quarter-2021-financial-results-on
https://www.nasdaq.com/press-release/bausch-lomb-announces-statistically-significant-topline-results-from-the-second-phase
https://www.nasdaq.com/press-release/bausch-health-releases-annual-environmental-social-and-governance-report-2021-09-29
https://www.nasdaq.com/press-release/salix-will-share-relistorr-methylnaltrexone-bromide-data-at-painweek-2021-2021-09-02
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2021-09-01
https://www.nasdaq.com/press-release/shareholder-alert%3a-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-82
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-second-quarter-2021-results-2021-08-03
https://www.nasdaq.com/press-release/bausch-health-announces-plans-to-pursue-an-initial-public-offering-of-solta-medical
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24350-million-2021-08-03
https://www.nasdaq.com/press-release/bausch-health-completes-sale-of-amoun-pharmaceutical-to-adq-2021-08-02
https://www.nasdaq.com/press-release/ortho-dermatologics-announces-2021-aspire-higher-scholarship-recipients-2021-07-29
https://www.nasdaq.com/press-release/salix-announces-2021-gastrointestinal-health-scholars-program-winners-2021-07-22
https://www.nasdaq.com/press-release/bausch-lomb-will-present-14-scientific-posters-featuring-new-analyses-involving-its
https://www.nasdaq.com/press-release/bausch-lomb-launches-biotruer-hydration-boost-lubricant-eye-drops-and-biotruer
https://www.nasdaq.com/press-release/bausch-lomb-completes-enrollment-of-second-phase-3-study-for-nov03
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-second-quarter-2021-financial-results-on
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24150-million-using-cash-generated-from-operations-0
https://www.nasdaq.com/press-release/bausch-lomb-expands-parameters-for-bausch-lomb-ultrar-multifocal-for-astigmatism
https://www.nasdaq.com/press-release/bausch-health-announces-extension-of-its-tender-offer-for-cash-tender-offer-for
https://www.nasdaq.com/press-release/bausch-health-announces-d.-robert-hale-has-resigned-from-its-board-of-directors-2021
https://www.nasdaq.com/press-release/bausch-lomb-and-lochan-enter-into-agreement-to-develop-the-next-generation-of
https://www.nasdaq.com/press-release/bausch-health-announces-early-tender-results-and-early-settlement-date-for-cash
https://www.nasdaq.com/press-release/bausch-health-and-clearside-biomedical-announce-u.s.-fda-filing-acceptance-for
https://www.nasdaq.com/press-release/bausch-lomb-and-prevent-blindness-launch-educational-campaign-during-cataract
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-5
https://www.nasdaq.com/press-release/bausch-health-announces-participation-at-the-jefferies-healthcare-conference-2021-05
https://www.nasdaq.com/press-release/bausch-health-announces-pricing-of-private-offering-of-senior-secured-notes-2021-05
https://www.nasdaq.com/press-release/bausch-health-commences-cash-tender-offer-for-any-and-all-of-its-7.00-senior-secured
https://www.nasdaq.com/press-release/bausch-health-announces-launch-of-private-offering-of-senior-secured-notes-and
https://www.nasdaq.com/press-release/salix-will-feature-new-data-at-digestive-disease-weekr-2021-2021-05-17
https://www.nasdaq.com/press-release/new-national-eye-institute-data-shows-areds2-nutrient-formula-continues-to-reduce-the
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2021-05-06
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-first-quarter-2021-results-2021-05-04
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-4
https://www.nasdaq.com/press-release/bausch-lomb-will-present-new-scientific-data-and-analyses-on-products-and-pipeline
https://www.nasdaq.com/press-release/bausch-health-announces-2021-annual-meeting-of-shareholder-results-2021-04-28
https://www.nasdaq.com/press-release/bausch-health-issues-form-8-k-for-2021-annual-meeting-of-shareholders-presentation
https://www.nasdaq.com/press-release/ortho-dermatologics-announces-statistically-significant-topline-results-from-second
https://www.nasdaq.com/press-release/ortho-dermatologics-to-present-new-data-at-the-2021-american-academy-of-dermatology
https://www.nasdaq.com/press-release/bausch-health-announces-vyzultar-latanoprostene-bunod-ophthalmic-solution-0.024-is-1
https://www.nasdaq.com/press-release/new-report-reveals-that-more-than-one-third-of-ibs-patients-surveyed-state-it-has
https://www.nasdaq.com/press-release/bausch-lomb-announces-statistically-significant-topline-results-from-the-first-phase
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-first-quarter-2021-financial-results-on-may
https://www.nasdaq.com/press-release/bausch-health-launches-envivetm-daily-probiotic-supplement-2021-04-08
https://www.nasdaq.com/press-release/fda-approves-bausch-lomb-clearvisctm-dispersive-ophthalmic-viscosurgical-device-2021
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-3
https://www.nasdaq.com/press-release/bausch-health-agrees-to-sell-amoun-pharmaceuticals-2021-03-31
https://www.nasdaq.com/press-release/salix-launches-gastrohub-for-advanced-practice-providers-an-educational-website
https://www.nasdaq.com/press-release/bausch-health-announces-cfo-succession-plan-2021-03-11
https://www.nasdaq.com/press-release/bausch-health-publishes-pipeline-update-for-the-barclays-global-healthcare-conference
https://www.nasdaq.com/press-release/solta-medical-announces-the-u.s.-launch-of-the-clear-brilliantr-touch-laser-2021-03
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-2
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-fourth-quarter-and-full-year-2020-results-and
https://www.nasdaq.com/press-release/bausch-health-announces-agreement-with-carl-c.-icahn-2021-02-24
https://www.nasdaq.com/press-release/bausch-lomb-launches-alawayr-preservative-free-antihistamine-eye-drops-2021-02-23
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-1
https://www.nasdaq.com/press-release/salix-announces-2021-gastrointestinal-health-scholars-program-2021-02-18
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2021-02-16
https://www.nasdaq.com/press-release/bausch-health-responds-to-schedule-13d-filing-from-icahn-capital-lp-2021-02-11
https://www.nasdaq.com/press-release/bausch-health-announces-vyzultar-latanoprostene-bunod-ophthalmic-solution-0.024-is-0
https://www.nasdaq.com/press-release/ortho-dermatologics-announces-2021-aspire-higher-scholarship-program-2021-02-02
https://www.nasdaq.com/press-release/prevent-blindness-and-bausch-lomb-to-launch-year-long-video-series-to-raise-awareness
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-fourth-quarter-and-full-year-2020-financial
https://www.nasdaq.com/press-release/south-koreas-mfds-approves-lumifyr-eye-drops-2021-01-21
https://www.nasdaq.com/press-release/bausch-lomb-announces-scientific-data-on-bausch-lomb-infusetm-silicone-hydrogel-daily
https://www.nasdaq.com/press-release/bausch-lomb-completes-enrollment-of-first-phase-3-study-for-nov03
https://www.nasdaq.com/press-release/bausch-health-provides-preliminary-update-on-fourth-quarter-and-full-year-2020
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-the-39th-annual-j.p.-morgan-healthcare-conference
https://www.nasdaq.com/press-release/bausch-healths-dexaven-dexamethasone-phosphate-receives-new-indication-in-poland-to
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24275-million-2020-12-29
https://www.nasdaq.com/press-release/bausch-health-initiates-second-phase-3-study-for-nov03-investigational-treatment-for
https://www.nasdaq.com/press-release/bausch-health-announces-pricing-and-upsize-of-private-offering-of-senior-notes-and-0
https://www.nasdaq.com/press-release/bausch-health-announces-launch-of-private-offering-of-senior-notes-and-conditional-0
https://www.nasdaq.com/press-release/bausch-health-announces-investigational-in-vitro-data-indicating-complete
https://www.nasdaq.com/press-release/bausch-lomb-reports-nearly-27-million-units-of-contact-lens-materials-recycled
https://www.nasdaq.com/press-release/salix-to-present-data-at-aaslds-the-liver-meeting-digital-experience-2020-11-11
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2020-11-10
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-third-quarter-2020-results-2020-11-03
https://www.nasdaq.com/press-release/bausch-healths-rifaximin-receives-fda-orphan-designation-for-sickle-cell-disease-2020
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24150-million-using-cash-generated-from-operations
https://www.nasdaq.com/press-release/bausch-lomb-introduces-simplifeyetm-iol-delivery-system-for-envistar-toric-and
https://www.nasdaq.com/press-release/ortho-dermatologics-to-present-new-analyses-at-the-virtual-fall-clinical-dermatology
https://www.nasdaq.com/press-release/salix-to-present-data-for-products-across-its-portfolio-at-the-american-college-of
https://www.nasdaq.com/press-release/bausch-health-and-bhvi-announce-exclusive-global-licensing-agreement-for-myopia
https://www.nasdaq.com/press-release/eyenovia-to-host-investor-call-to-discuss-recent-licensing-agreements-resulting-in
https://www.nasdaq.com/press-release/bausch-health-licenses-eyenovias-investigational-treatment-for-the-reduction-of
https://www.nasdaq.com/press-release/salix-to-present-clinical-data-at-united-european-gastroenterology-week-virtual-2020
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-provides-preliminary-update-on-third-quarter-2020
https://www.nasdaq.com/press-release/bausch-lomb-announces-new-scientific-and-clinical-analyses-to-be-presented-on-bausch
https://www.nasdaq.com/press-release/salix-supports-liver-awareness-month-with-new-educational-initiatives-2020-10-05
https://www.nasdaq.com/press-release/nielsens-bases-names-lumifyr-eye-drops-to-2020-u.s.-bases-top-25-breakthrough
https://www.nasdaq.com/press-release/fda-approves-bausch-lomb-alawayr-preservative-free-ketotifen-fumarate-ophthalmic
https://www.nasdaq.com/press-release/bausch-health-announces-vyzultar-latanoprostene-bunod-ophthalmic-solution-0.024-is
https://www.nasdaq.com/press-release/bausch-health-releases-annual-corporate-social-responsibility-report-2020-09-23
https://www.nasdaq.com/press-release/bausch-health-and-alfasigma-announce-resolution-of-xifaxanr-intellectual-property-0
https://www.nasdaq.com/press-release/bausch-health-to-acquire-option-to-purchase-all-ophthalmology-assets-of-allegro
https://www.nasdaq.com/press-release/bausch-health-provides-company-update-at-18th-annual-morgan-stanley-global-healthcare
https://www.nasdaq.com/press-release/bausch-foundation-releases-inaugural-activity-report-2020-09-10
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-the-18th-annual-morgan-stanley-global-healthcare
https://www.nasdaq.com/press-release/sol-gel-technologies-collaboration-partner-filed-first-to-file-paragraph-iv
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations-0
https://www.nasdaq.com/press-release/australias-tga-approves-bausch-lomb-ultrar-one-day-silicone-hydrogel-daily-disposable
https://www.nasdaq.com/press-release/bausch-lomb-launches-innovative-bausch-lomb-infusetm-silicone-hydrogel-sihy-daily
https://www.nasdaq.com/press-release/health-canada-approves-bausch-lomb-ultra-one-dayr-silicone-hydrogel-daily-disposable
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-second-quarter-2020-results-2020-08-06
https://www.nasdaq.com/press-release/bausch-health-announces-its-intention-to-spin-off-its-eye-health-business-into-an
https://www.nasdaq.com/press-release/bausch-health-resolves-canadian-securities-class-action-2020-08-05
https://www.nasdaq.com/press-release/bausch-health-resolves-legacy-sec-investigation-2020-07-31
https://www.nasdaq.com/press-release/ortho-dermatologics-announces-2020-aspire-higher-scholarship-recipients-2020-07-28
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-second-quarter-2020-financial-results-on
https://www.nasdaq.com/press-release/ortho-dermatologics-launches-arazlotm-tazarotene-lotion-0.045-in-the-united-states
https://www.nasdaq.com/press-release/bausch-lomb-ultrar-silicone-hydrogel-contact-lenses-receive-approval-in-china-2020-06
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-goldman-sachs-annual-leveraged-finance-conference
https://www.nasdaq.com/press-release/salix-announces-inaugural-salix-gastrointestinal-health-scholars-program-recipients
https://www.nasdaq.com/press-release/fda-provides-510k-clearance-for-bausch-lomb-infusetm-daily-disposable-silicone
https://www.nasdaq.com/press-release/bausch-lomb-announces-the-european-launch-of-luxsmarttm-and-luxgoodtm-preloaded
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-goldman-sachs-annual-global-healthcare-conference
https://www.nasdaq.com/press-release/bausch-health-announces-pricing-and-upsize-of-private-offering-of-senior-notes-and
https://www.nasdaq.com/press-release/bausch-health-announces-launch-of-private-offering-of-senior-notes-and-conditional
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-first-quarter-2020-results-2020-05-07
https://www.nasdaq.com/press-release/bausch-health-and-alfasigma-announce-resolution-of-xifaxanr-intellectual-property
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-2020-bank-of-america-merrill-lynch-global-healthcare
https://www.nasdaq.com/press-release/salix-to-highlight-new-data-across-its-portfolio-of-products-at-digestive-disease
https://www.nasdaq.com/press-release/bausch-health-announces-2020-annual-meeting-of-shareholder-results-2020-04-29
https://www.nasdaq.com/press-release/fda-approves-ortho-dermatologics-labeling-for-jubliar-efinaconazole-topical-solution
https://www.nasdaq.com/press-release/bausch-health-issues-form-8-k-for-2020-annual-meeting-of-shareholders-presentation
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-first-quarter-2020-financial-results-on-may
https://www.nasdaq.com/press-release/bausch-lomb-announces-publication-of-10-year-armor-study-results-on-ocular-antibiotic
https://www.nasdaq.com/press-release/bausch-health-initiates-virazoler-ribavirin-for-inhalation-solution-usp-clinical
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-hold-virtual-annual-meeting-of-shareholders-on
https://www.nasdaq.com/press-release/bausch-health-announces-favorable-topline-results-from-study-evaluating-investigative
https://www.nasdaq.com/press-release/bausch-health-donates-health-care-products-and-supplies-through-bausch-foundation-in
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-approximately-%24100-million-using-cash-generated-from
https://www.nasdaq.com/press-release/bausch-health-announces-it-will-no-longer-pursue-proposed-refinancing-transaction-and
https://www.nasdaq.com/press-release/bausch-health-announces-it-is-seeking-a-refinancing-amendment-to-its-existing-credit
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-announces-fourth-quarter-and-full-year-2019-results-and
https://www.nasdaq.com/press-release/ortho-dermatologics-launches-telemedicine-on-dermatology.com-u.s.-cash-pay
https://www.nasdaq.com/press-release/bausch-health-to-reduce-debt-by-%24100-million-using-cash-generated-from-operations
https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2020-02-04
https://www.nasdaq.com/press-release/bausch-lomb-and-prevent-blindness-join-together-to-raise-awareness-and-provide
https://www.nasdaq.com/press-release/ortho-dermatologics-opens-2020-aspire-higher-scholarship-program-2020-02-03
https://www.nasdaq.com/press-release/bausch-health-and-clearside-biomedical-announce-publication-of-pivotal-phase-3-data
https://www.nasdaq.com/press-release/bausch-health-companies-inc.-will-release-fourth-quarter-and-full-year-2019-financial
https://www.nasdaq.com/press-release/bausch-health-publishes-company-update-for-the-38th-annual-j.p.-morgan-healthcare
https://www.nasdaq.com/press-release/ortho-dermatologics-announces-publication-of-pivotal-phase-3-data-on-arazlotm
https://www.nasdaq.com/press-release/bausch-lomb-launches-expanded-parameters-for-biotruer-oneday-for-astigmatism-daily
https://www.nasdaq.com/press-release/bausch-health-to-participate-at-the-38th-annual-j.p.-morgan-healthcare-conference
https://www.nasdaq.com/press-release/bausch-health-announces-resolution-of-bryhalir-halobetasol-propionate-lotion-0.01
https://www.nasdaq.com/press-release/bausch-lomb-initiates-clinical-trial-evaluating-new-cohesive-ophthalmic-viscosurgical
https://www.nasdaq.com/press-release/bausch-health-announces-launch-of-private-offering-of-senior-notes-2019-12-17
https://www.nasdaq.com/press-release/bausch-health-resolves-stock-drop-litigation-initially-filed-in-october-2015-2019-12
https://www.nasdaq.com/press-release/bausch-lomb-and-terracycle-announce-donation-of-new-custom-training-modules
https://www.nasdaq.com/press-release/bausch-health-companies-announces-participation-in-upcoming-investor-conferences-0
https://www.nasdaq.com/press-release/salix-announces-issuance-of-an-additional-xifaxanr-patent-2019-10-31
https://www.nasdaq.com/press-release/salix-pharmaceuticals-announces-inaugural-scholarship-program-to-commemorate-its-30th
